Quantum Genomics SA QNNTF
$0.10
Last Updated: Mar 07, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
QNNTF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Quantum Genomics SA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Quantum Genomics SA. Stock Analysis QNNTF
United States Health Care Nano Cap Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. The company is headquartered in Paris, Ile-De-France and currently employs 3 full-time employees. The company went IPO on 2009-07-28. The firm is a biopharmaceutical company dedicated to developing new therapies for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure. Its main activity is in research and development of new therapies for the treatment of hypertension, BAPAI (Brain Aminopeptidase A Inhibitors) oriented in the field of cardiovascular diseases, especially high blood pressure and heart failure. The firm also co-develops products with academic teams, biotechnological research entities, and some of the pharmaceutical and bio-science companies. The firm is involved in four research programs. Quantum Genomics also collaborates with Center for Clinical Investigation 9201 APHP / INSERM of the Georges Pompidou European Hospital in Paris, among others.
Quantum Genomics SA (QNNTF) Chart
Financial Metrics & Statements of Quantum Genomics SA (QNNTF)
FAQ's for Quantum Genomics SA (QNNTF)
- As of August 2026, Quantum Genomics SA QNNTF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Quantum Genomics SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Quantum Genomics SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Quantum Genomics SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Quantum Genomics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Quantum Genomics SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Quantum Genomics SA (QNNTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
